Ozempic, a popular weight loss medication, is set to face competition from tirzepatide, also known as Mounjaro, which may be more effective for blood sugar control and weight loss, potentially approved by the US FDA this year. Mounjaro, also known as tirzepatide, is an FDA-approved prescription drug used to treat